Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1427.9000 3.10 (0.22%)
NSE Dec 22, 2025 15:31 PM
Volume: 80,833
 

logo
Ipca Laboratories Ltd.
30 Sep 2024
1427.90
0.22%
buy
by Sharekhan
Target: 1734
Sharekhan
Ipca’s board would discuss the strategic integration of Bayshore Pharmaceuticals’ generics business into Unichem Pharma (USA) Inc on September 30, 2024.
 
Ipca Laboratories Ltd. is trading above all available SMAs
More from Ipca Laboratories Ltd.
Recommended
IPO market stays hot this week with KSH International's listing and eleven new issues
| 22 Dec 2025, 05:22PM
Market closes higher amid foreign investor inflows & rupee stabilization
Trendlyne Marketwatch | 22 Dec 2025, 04:09PM
IPCA Labs’ domestic formulations business to drive growth
| 05 Jul 2021